2024
Praveen-Kumar A, Vicente D, Liu J, Raj-Kumar PK, Deyarmin B, Lin X, Shriver CD and Hu H. Association of clinicopathologic and molecular factors with the occurrence of positive margins in breast cancer. Breast Cancer Res Treat 2024;204(1):15-26.10.1007/s10549-023-07157-x.
Raj-Kumar PK, Lin X, Liu T, Sturtz LA, Gritsenko MA, Petyuk VA, Sagendorf TJ, Deyarmin B, Liu J, Praveen-Kumar A, Wang G, McDermott JE, Shukla AK, Moore RJ, Monroe ME, Webb-Robertson BM, Hooke JA, Fantacone-Campbell L, Mostoller B, Kvecher L, Kane J, Melley J, Somiari S, Soon-Shiong P, Smith RD, Mural RJ, Rodland KD, Shriver CD, Kovatich AJ and Hu H. Proteogenomic characterization of difficult-to-treat breast cancer with tumor cells enriched through laser microdissection. Breast Cancer Res 2024;26(1):76.10.1186/s13058-024-01835-4.
Spencer JV, Liu J, Deyarmin B, Hu H, Shriver CD and Somiari S. Cytokine levels in breast cancer are highly dependent on cytomegalovirus (CMV) status. Breast Cancer Res Treat 2024;10.1007/s10549-024-07459-8.
Teng P, Schaff J, Abulez T, Hood B, Wilson K, Litzi T, Mitchell D, Conrads K, Hunt A, Olowu V, Oliver J, Park F, Edwards M, Chiang A, Wilkerson M, Raj-Kumar P, Tarney C, Darcy K, Phippen N, Maxwell G, Conrads T and Bateman N. ProteoMixture: A Cell Type Deconvolution Tool for Bulk Tissue Proteomic Data. iScience 2024;10.1016/j.isci.2024.109198.
Zhang J, Rui H and Hu H. Noninvasive multi-cancer detection using blood-based cell-free microRNAs. Scientific Reports 2024;14(1):22136.10.1038/s41598-024-73783-0.
2023
Chervoneva I, Peck AR, Sun Y, Yi M, Udhane SS, Langenheim JF, Girondo MA, Jorns JM, Chaudhary LN, Kamaraju S, Bergom C, Flister MJ, Hooke JA, Kovatich AJ, Shriver CD, Hu H, Palazzo JP, Bibbo M, Hyslop T, Nevalainen MT, Pestell RG, Fuchs SY, Mitchell EP and Rui H. High PD-L2 Predicts Early Recurrence of ER-Positive Breast Cancer. JCO Precis Oncol 2023;7:e2100498.10.1200/po.21.00498.
Darmon S, Lovejoy LA, Shriver CD, Zhu K and Ellsworth RE. Nondisparate Survival of Non-Hispanic Black Women With Breast Cancer Despite Less Favorable Pathology: Effect of Access to and Provision of Care Within a Military Health Care System. Health Equity 2023;7(1):178-184.10.1089/heq.2022.0128.
Lovejoy L, Shriver CD, Haricharan S and Ellworth RE. Survival Disparities in US Black Compared to White Women with Hormone Receptor Positive-HER2 Negative Breast Cancer. Int. DJ. Environ. Res. Public Health 2023;(23):2903.10.3390/ijerph20042903.
Praveen-Kumar A, Vicente C, Liu J, Raj-Kumar PK, Deyarmin B, Lin X, Shriver CD and Hu H. Association of clinicopathologic and molecular factors with the occurrence of positive margins in breast cancer. Breast Cancer Research and Treatment 2023;10.1007/s10549-023-07157-x.
Yi M, Zhan T, Peck AR, Hooke JA, Kovatich AJ, Shriver CD, Hu H, Sun Y, Rui H and Chervoneva I. Quantile Index Biomarkers Based on Single-Cell Expression Data. Lab Invest 2023;103(8):100158.10.1016/j.labinv.2023.100158.
Bateman NW, Tarney CM, Abulez TS, Hood BL, Conrads KA, Zhou M, Soltis AR, Teng PN, Jackson A, Tian C, Dalgard CL, Wilkerson MD, Kessler MD, Goecker Z, Loffredo J, Shriver CD, Hu H, Cote M, Parker GJ, Segars J, Al-Hendy A, Risinger JI, Phippen NT, Casablanca Y, Darcy KM, Maxwell GL, Conrads TP and O’Connor TD. Peptide ancestry informative markers in uterine neoplasms from women of European, African, and Asian ancestry. iScience 2022;25(1):103665.10.1016/j.isci.2021.103665.
Darmon S, Park A, Lovejoy L, Shriver CD, Zhu K and Ellsworth RE. Relationship between Cigarette Smoking and Cancer Characteristics and Survival among Breast Cancer Patients. Int. DJ. Environ. Res. Public Health 2022;2022(19, 4084)10.3390/ijerph19074084.
Maisel BA, Yi M, Peck AR, Sun Y, Hooke JA, Kovatich AJ, Shriver CD, Hu H, Nevalainen MT, Tanaka T, Simone N, Wang LL, Rui H and Chervoneva I. Spatial Metrics of Interaction between CD163-Positive Macrophages and Cancer Cells and Progression-Free Survival in Chemo-Treated Breast Cancer. Cancers (Basel) 2022;14(2)10.3390/cancers14020308.
Somiari SB, Shuss S, Liu J, Mamula K, O’Donnell A, Deyarmin B, Kane J, Greenawalt A, Larson C, Rigby S, Hu H and Shriver CD. Assessing the quality of RNA isolated from human breast tissue after ambient room temperature exposure. PLoS One 2022;17(1):e0262654.10.1371/journal.pone.0262654.
Yu P, Kazemier G, Brandlund I, Tasneem A, Wiberg H, Wesdorp NJ, Lambrecht M, Hu H, Winn RA, Kearney S, Huiskens J and Granger E. Artificial intelligence comes of age in the fight against cancer. Oncology Times 2022;44(3):1,15-16.
Zhang A and Hu H. A novel blood-based microRNA diagnostic model with high accuracy for multi-cancer early detection. Cancers 2022;14(6):1450.
Lin J, Hu H, Shriver CD and Zhu K. Survival among Breast Cancer Patients: Comparison of the U.S. Military Health System with the Surveillance, Epidemiology and End Results Program. Clin Breast Cancer 2021;10.1016/j.clbc.2021.11.010.
Lovejoy LA, Rummel SK, Turner CE, Shriver CD and Ellsworth RE. Frequency and spectrum of mutations across 94 cancer predisposition genes in African American women with invasive breast cancer. Fam Cancer 2021;20(3):181-187.
Lovejoy LA, Turner CE, Shriver CD and Ellsworth RE. Cancer Previvors in an Active Duty Service Women Population: An Opportunity for Prevention and Increased Force Readiness. Mil Med 2021;186(7-8):e737-e742.
Bera A, Russ E, Srinivasan M, Eidelman O, Eklund M, Hueman M, Pollard HB, Hu H, Shriver CD and Srivastava M. Proteomic Analysis of Inflammatory Biomarkers Associated With Breast Cancer Recurrence. Mil Med 2020;185(Supplement_1):669-675.10.1093/milmed/usz254.
Bera A, Subramanian M, Karaian J, Eklund M, Radhakrishnan S, Gana N, Rothwell S, Pollard H, Hu H, Shriver CD and Srivastava M. Functional role of vitronectin in breast cancer. PLoS One 2020;15(11):e0242141.10.1371/journal.pone.0242141.
Lovejoy L, Turner C, Wells JM, Shriver CD and Ellsworth R. Hertability of Low ER Staining/Her2-Breast Tumors: Are We Missing an Opportunity for Germline Testing? Genes 2020;2020(11)10.3390/genes1112149.
Odnokoz O, Yu P, Peck AR, Sun Y, Kovatich AJ, Hooke JA, Hu H, Mitchell EP, Rui H and Fuchs SY. Malignant cell-specific pro-tumorigenic role of type I interferon receptor in breast cancers. Cancer Biol Ther 2020:1-8.10.1080/15384047.2020.1750297.
Rummel S, Lovejoy L, Turner C, Shriver CD and Ellsworth RE. Should genetic testing or cancer predisposition be standard-of-care for women with invasive breast cancer? The Murtha Cancer Center Experience. Cancers 2020;2020(12, 234)10.3390/cancers 12010234.
Sturtz LA, Wang G, Shah P, Searfoss R, Raj-Kumar PK, Hooke JA, Fantacone-Campbell JL, Deyarmin B, Cutler ML, Sarangarajan R, Narain NR, Hu H, Kiebish MA, Kovatich AJ and Shriver CD. Comparative analysis of differentially abundant proteins quantified by LC-MS/MS between flash frozen and laser microdissected OCT-embedded breast tumor samples. Clin Proteomics 2020;17(1):020-09300.
Zhang Y, Liu J, Raj-Kumar PK, Sturtz LA, Praveen-Kumar A, Yang HH, Lee MP, Fantacone-Campbell JL, Hooke JA, Kovatich AJ, Shriver CD and Hu H. Development and validation of prognostic gene signature for basal-like breast cancer and high-grade serous ovarian cancer. Breast Cancer Res Treat 2020;10.1007/s10549-020-05884-z.